Search research articles
Contact Us
Filters
Showing results (11-20 of 114) with videos related to
Page
of 12
Sort By:
Frontiers in Artificial Intelligence
|
February 9, 2026
Orchestrating segment anything models to accelerate segmentation annotation on agricultural image datasets
Leon H Oehme, Jonas Boysen, Zhangkai Wu, et al.
Leukemia & Lymphoma
|
February 28, 2023
Report of four acute myeloid leukemia patients with sustained complete remission with less frequent administration of decitabine and venetoclax
Ahmed Aribi, Amandeep Salhotra, Brian Ball, et al.
Leukemia & Lymphoma
|
January 22, 2020
A systematic review of outcomes after stem cell transplantation in acute lymphoblastic leukemia with or without measurable residual disease
Shweta Shah, Amber Martin, Monica Turner, et al.
American Journal of Hematology
|
June 1, 2010
C/EBPA gene mutation and C/EBPA promoter hypermethylation in acute myeloid leukemia with normal cytogenetics
Ying Lu, Wengang Chen, Wei Chen, et al.
Onkologie
|
May 24, 2008
Male breast cancer 15 years after allogeneic hematopoietic cell transplantation including total body irradiation for recurrent acute lymphoblastic leukemia
Thomas Lowe, Thehang Luu, Jeannie Shen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 17, 2017
Total Marrow Lymphoid Irradiation/Fludarabine/ Melphalan Conditioning for Allogeneic Hematopoietic Cell Transplantation
Lindsay G Jensen, Tracey Stiller, Jeffrey Y C Wong, et al.
British Journal of Haematology
|
May 15, 2008
A rapid, one step assay for simultaneous detection of FLT3/ITD and NPM1 mutations in AML with normal cytogenetics
Qin Huang, Wengang Chen, Karl K Gaal, et al.
American Journal of Hematology
|
February 1, 2021
Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agents
Tamer A Othman, Matthew Mei, Jianying Zhang, et al.
Bone Marrow Transplantation
|
February 23, 2022
Successful treatment of refractory pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplant with single agent Ibrutinib
Shukaib Arslan, Haris Ali, Mathew Mei, et al.
Blood
|
September 30, 2010
Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies
Joseph Rosenthal, Jeffrey Wong, Anthony Stein, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 114) with videos related to
Sort By:
Page
of 12
Frontiers in Artificial Intelligence
|
February 9, 2026
Orchestrating segment anything models to accelerate segmentation annotation on agricultural image datasets
Leon H Oehme, Jonas Boysen, Zhangkai Wu, et al.
Leukemia & Lymphoma
|
February 28, 2023
Report of four acute myeloid leukemia patients with sustained complete remission with less frequent administration of decitabine and venetoclax
Ahmed Aribi, Amandeep Salhotra, Brian Ball, et al.
Leukemia & Lymphoma
|
January 22, 2020
A systematic review of outcomes after stem cell transplantation in acute lymphoblastic leukemia with or without measurable residual disease
Shweta Shah, Amber Martin, Monica Turner, et al.
American Journal of Hematology
|
June 1, 2010
C/EBPA gene mutation and C/EBPA promoter hypermethylation in acute myeloid leukemia with normal cytogenetics
Ying Lu, Wengang Chen, Wei Chen, et al.
Onkologie
|
May 24, 2008
Male breast cancer 15 years after allogeneic hematopoietic cell transplantation including total body irradiation for recurrent acute lymphoblastic leukemia
Thomas Lowe, Thehang Luu, Jeannie Shen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 17, 2017
Total Marrow Lymphoid Irradiation/Fludarabine/ Melphalan Conditioning for Allogeneic Hematopoietic Cell Transplantation
Lindsay G Jensen, Tracey Stiller, Jeffrey Y C Wong, et al.
British Journal of Haematology
|
May 15, 2008
A rapid, one step assay for simultaneous detection of FLT3/ITD and NPM1 mutations in AML with normal cytogenetics
Qin Huang, Wengang Chen, Karl K Gaal, et al.
American Journal of Hematology
|
February 1, 2021
Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agents
Tamer A Othman, Matthew Mei, Jianying Zhang, et al.
Bone Marrow Transplantation
|
February 23, 2022
Successful treatment of refractory pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplant with single agent Ibrutinib
Shukaib Arslan, Haris Ali, Mathew Mei, et al.
Blood
|
September 30, 2010
Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies
Joseph Rosenthal, Jeffrey Wong, Anthony Stein, et al.
Page
of 12